Challenges and Potential Preventive Measures for the Immunocompromised Community During COVID-19

The COVID-19 pandemic has presented unique challenges for the immunocompromised community, who are struggling to find effective protection against the virus. With the withdrawal of monoclonal antibody treatments from the market, this vulnerable group is facing a shortage of resources to safeguard themselves. In light of this, many are turning to supplements, vitamins, and other products in the hope of strengthening their resilience against COVID-19. Among the commonly studied supplements are vitamin C, vitamin D, zinc, copper, iron, N-acetylcysteine, and quercetin. However, the evidence regarding their effectiveness is inconclusive due to confounding variables and the limitations of well-designed clinical trials. Despite the potential of antiviral drugs in preventing the progression from mild-to-moderate disease to severe illness in COVID-19, their utilization remains remarkably low in the general adult population. Recognizing the value of antiviral drugs in preventing severe disease outcomes is crucial, particularly for patients with comorbidities. Amidst these challenges, the importance of standard precautions and vaccination cannot be overstated.